 SAN FRANCISCO, Oct. 06, 2021 GLOBE NEWSWIRE -- Vir Biotechnology, Inc. Nasdaq: VIR today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the H. C. Wainwright 2nd Annual Hepatitis B Virus HBV Conference on Wednesday, Oct. 13, at 9:30 a.m. PT 12:30 p.m. ET. 